The prothrombin 20209 c fi t mutation in jewish-moroccan caucasians: Molecular analysis of gain-of-function of 3' end processing

Journal of Tissue Engineering and Regenerative Medicine

Volumn 4, Issue 5, 2006, Pages 1078-1085

  Danckwardt, S ^a   Hartmann, K ^a   Katz, B ^b   Hentze, M W ^a,c   Levy, Y ^b   Eichele, R ^b   Deutsch, V ^b   Kulozik, A E ^a   Ben Tal, O ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

Fetal loss; Infertility; Mrna processing; Polyadenylation; Prothrombin (F2) 20209; T; Thrombophilia

Indexed keywords

DISEASES; FUNCTIONAL ANALYSIS; GENES; GLYCOPROTEINS;

CAUCASIANS; FETAL LOSS; GAIN-OF FUNCTION; INFERTILITY; MOLECULAR ANALYSIS; MRNA PROCESSING; POLYADENYLATION; PROTHROMBIN (F2) 20209; T; THROMBOPHILIUM;

OBSTETRICS;

CYTOSINE; MESSENGER RNA; PRIMER DNA; PROTHROMBIN; THYMINE;

ADULT; AGED; ARTICLE; CAUCASIAN; CHEMISTRY; ETHNOLOGY; FEMALE; GENETICS; HUMAN; JEW; MALE; METABOLISM; MOROCCO; MUTATION; NUCLEOTIDE SEQUENCE; RNA PROCESSING;

ADULT; AGED; BASE SEQUENCE; CYTOSINE; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; JEWS; MALE; MOROCCO; MUTATION; PROTHROMBIN; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; THYMINE;

EID: 84878087331     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01885.x     Document Type: Article

References (27)

1. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-31.
2. Wylenzek M, Geisen C, Stapenhorst L, Wielckens K, Klingler KR. A novel point mutation in the 3' region of the prothrombin gene at position 20221 in a Lebanese/Syrian family. ThrombHaemost 2001; 85: 943-4.3.
3. Balim Z, Kosova B, Falzon K, Bezzina WS, Colak Y. Budd-Chiari syndrome in a patient heterozygous for the pointmutation C20221T of the prothrombin gene. J Thromb Haemost 2003; 1: 852-3.
4. Schrijver I, Lenzi TJ, Jones CD, Lay MJ, Druzin ML, Zehnder JL. Prothrombin gene variants in non-Caucasians with fetal loss and intrauterine growth retardation. J Mol Diagn 2003; 5: 250-3.
5. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
6. Soria JM, Almasy L, Souto JC, Tirado I, Borell M, Mateo J, Slifer S, Stone W, Blangero J, Fontcuberta J. Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis. Blood 2000; 95: 2780-5.
7. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13.
8. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003; 361: 901-8.
9. Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, Hentze MW, Kulozik AE. Increased efficiency of mRNA 3' end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat Genet 2001; 28: 389-92.
10. Carter AM, Sachchithananthan M, Stasinopoulos S, Maurer F, Medcalf RL. Prothrombin G20210A is a bifunctional gene polymorphism. Thromb Haemost 2002; 87: 846-53.
11. Ceelie H, Spaargaren-van Riel CC, Bertina RM, Vos HL. G20210A is a functional mutation in the prothrombin gene; effect on protein levels and 3'-end formation. J Thromb Haemost 2004; 2: 119-27.
12. Danckwardt S, Gehring NH, Neu-Yilik G, Hundsdoerfer P, Pforsich M, Frede U, Hentze MW, Kulozik AE. The prothrombin 3'end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations. Blood 2004; 104: 428-35.
13. Pollak ES, Lam HS, Russell JE. The G20210A mutation does not affect the stability of prothrombin mRNA in vivo. Blood 2002; 100: 359-62.
14. Sachchithananthan M, Stasinopoulos SJ, Wilusz J, Medcalf RL. The relationship between the prothrombin upstream sequence element and the G20210A polymorphism: the influence of a competitive environment for mRNA 3'-end formation. Nucl Acids Res 2005; 33: 1010-20.
15. Zhao J, Hyman L, Moore C. Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 1999; 63: 405-45.
16. Chen F, MacDonald CC, Wilusz J. Cleavage site determinants in the mammalian polyadenylation signal. Nucleic Acids Res 1995; 23: 2614-20.
17. Danckwardt S, Hartmann K, GehringNH, Hentze MW, Kulozik AE. 3' end processing of the prothrombin mRNA in thrombophilia. Acta Haematol 2006; 115: 192-7.
18. Warshawsky I, HrenC, SerciaL, ShadrachB, Deitcher SR, NewtonE, Kottke-Marchant K. Detection of a novel point mutation of the prothrombin gene at position 20209. Diagn Mol Pathol 2002; 11: 152-6.
19. Soo PY, Patel RK, Best S, Arya R, Thein SL. Detection of prothrombin gene polymorphism at position 20209 (PT20209C/T): pilot study in a black population in the United Kingdom. Thromb Haemost 2005; 93: 179-80.
20. van den Bergh FA, van Oeveren-Dybicz AM, Bon MA. Rapid singletube genotyping of the factor V Leiden and prothrombin mutations by real-time PCR using dual-color detection. Clin Chem 2000; 46: 1191-5.
21. Danckwardt S, Neu-Yilik G, Thermann R, Frede U, Hentze MW, Kulozik AE. Abnormally spliced beta-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsensemediated mRNA decay. Blood 2002; 99: 1811-6.
22. Ferraresi P, Marchetti G, Legnani C, Cavallari E, Castoldi E, Mascoli F, Ardissino D, Palareti G, Bernardi F. The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler Thromb Vasc Biol 1997; 17: 2418-22.
23. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, AiachM, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706-8.
24. Zivelin A, RosenbergN, Faier S, Kornbrot N, Peretz H, Mannhalter C, HorellouMH, Seligsohn U. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 1998; 92: 1119-24.
25. Lyon E. Discovering rare variants by use of melting temperature shifts seen in melting curve analysis. Clin Chem 2005; 51: 1331-2.
26. CeelieH, Spaargaren-Van Riel CC, De JongM, Bertina RM, VosHL. Functional characterization of transcription factor binding sites for HNF1-alpha, HNF3-beta (FOXA2),HNF4-alpha, Sp1 and Sp3 in the human prothrombin gene enhancer. J ThrombHaemost 2003; 1: 1688-98.
27. Lin KH, Lee HY, Shih CH, Yen CC, Chen SL, Yang RC, Wang CS. Plasma protein regulation by thyroid hormone. J Endocrinol 2003; 179: 367-77.